Ralph A. Highshaw

857 total citations
13 papers, 685 citations indexed

About

Ralph A. Highshaw is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ralph A. Highshaw has authored 13 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ralph A. Highshaw's work include Bladder and Urothelial Cancer Treatments (4 papers), Urological Disorders and Treatments (3 papers) and Ubiquitin and proteasome pathways (2 papers). Ralph A. Highshaw is often cited by papers focused on Bladder and Urothelial Cancer Treatments (4 papers), Urological Disorders and Treatments (3 papers) and Ubiquitin and proteasome pathways (2 papers). Ralph A. Highshaw collaborates with scholars based in United States and Japan. Ralph A. Highshaw's co-authors include David J. McConkey, Peng Huang, James L. Abbruzzese, Kenneth Dunner, Jennifer S. Carew, Steffan T. Nawrocki, Maria Simona Pino, Paul J. Chiao, Colleen Sweeney and Henry Xiong and has published in prestigious journals such as Cancer Research, The Journal of Urology and European Urology.

In The Last Decade

Ralph A. Highshaw

13 papers receiving 665 citations

Peers

Ralph A. Highshaw
Charity Atkins United States
Ralph A. Highshaw
Citations per year, relative to Ralph A. Highshaw Ralph A. Highshaw (= 1×) peers Charity Atkins

Countries citing papers authored by Ralph A. Highshaw

Since Specialization
Citations

This map shows the geographic impact of Ralph A. Highshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph A. Highshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph A. Highshaw more than expected).

Fields of papers citing papers by Ralph A. Highshaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph A. Highshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph A. Highshaw. The network helps show where Ralph A. Highshaw may publish in the future.

Co-authorship network of co-authors of Ralph A. Highshaw

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph A. Highshaw. A scholar is included among the top collaborators of Ralph A. Highshaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph A. Highshaw. Ralph A. Highshaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Spiess, Philippe E., Wassim Kassouf, Gordon Brown, et al.. (2006). Immediate versus staged urethrectomy in patients at high risk of urethral recurrence: Is there a benefit to either approach?. Urology. 67(3). 466–471. 16 indexed citations
2.
Nawrocki, Steffan T., Jennifer S. Carew, Maria Simona Pino, et al.. (2006). Aggresome Disruption: A Novel Strategy to Enhance Bortezomib-Induced Apoptosis in Pancreatic Cancer Cells. Cancer Research. 66(7). 3773–3781. 193 indexed citations
3.
Kassouf, Wassim, et al.. (2006). Vitamins C and K3 Sensitize Human Urothelial Tumors to Gemcitabine. The Journal of Urology. 176(4). 1642–1647. 36 indexed citations
4.
Nawrocki, Steffan T., Jennifer S. Carew, Maria Simona Pino, et al.. (2005). Bortezomib Sensitizes Pancreatic Cancer Cells to Endoplasmic Reticulum Stress-Mediated Apoptosis. Cancer Research. 65(24). 11658–11666. 253 indexed citations
5.
Highshaw, Ralph A., David J. McConkey, & Colin P. Dinney. (2004). Integrating basic science and clinical research in bladder cancer: update from the first bladder Specialized Program of Research Excellence (SPORE). Current Opinion in Urology. 14(5). 295–300. 14 indexed citations
6.
Highshaw, Ralph A., Funda Vakar‐Lopez, Eric Jonasch, Alan W. Yasko, & Surena F. Matin. (2004). Port-Site Metastasis: The Influence of Biology. European Urology. 47(3). 357–360. 18 indexed citations
7.
Highshaw, Ralph A., Stacy T. Tanaka, Christopher P. Evans, & Ralph W. deVere White. (2003). Is bladder biopsy necessary at three or six months post BCG therapy?. Urologic Oncology Seminars and Original Investigations. 21(3). 207–209. 13 indexed citations
8.
Wu, Xifeng, et al.. (2003). The phosphatidylinositol‐3 kinase pathway regulates bladder cancer cell invasion. British Journal of Urology. 93(1). 143–150. 91 indexed citations
9.
Shi, Xu-Bao, Ralph A. Highshaw, Arline D. Deitch, et al.. (2002). Application of a Yeast Assay to Detect Functional p53 Mutations in Archival Prostate Cancer Tissue. Cancer Biotherapy and Radiopharmaceuticals. 17(6). 657–664. 6 indexed citations
10.
Highshaw, Ralph A., Hari Tunuguntla, Richard V. Perez, Regina Gandour‐Edwards, & Christopher P. Evans. (2002). Initial report of bladder carcinoma following combined bladder‐drained pancreas and kidney transplantation. Clinical Transplantation. 16(5). 383–386. 1 indexed citations
11.
Akalu, Abebe, Donald A. Elmajian, Ralph A. Highshaw, Peter W. Nichols, & Juergen Reichardt. (1999). SOMATIC MUTATIONS AT THE SRD5A2 LOCUS ENCODING PROSTATIC STEROID 5 alpha-REDUCTASE DURING PROSTATE CANCER PROGRESSION. The Journal of Urology. 161(4). 1355–1358. 25 indexed citations
12.
Akalu, Abebe, Donald A. Elmajian, Ralph A. Highshaw, Peter W. Nichols, & Juergen Reichardt. (1999). SOMATIC MUTATIONS AT THE SRD5A2 LOCUS ENCODING PROSTATIC STEROID 5 alpha-REDUCTASE DURING PROSTATE CANCER PROGRESSION. The Journal of Urology. 1355–1358. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026